Growblox Announces Commercialization Initiative and Financing
GlobeNewswire - Wed May 13, 7:00AM CDT
Growblox Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today it has established Growblox Sciences Puerto Rico, LLC ("GBS PR"
Growblox Sciences Announces Launch of New Corporate Website
GlobeNewswire - Mon May 11, 11:21AM CDT
Growblox Sciences Inc. (OTCQB:GBLX) ("Growblox" or the "Company"
Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part IV
Anthony Cataldo - at Seeking Alpha - Fri Apr 17, 12:54PM CDT
FULL: 3.52 (-0.01), GWPH: 112.25 (-0.07)
Building A 'Risk-Adverse' Pot Stock Portfolio
Matthew Finston - at Seeking Alpha - Mon Mar 09, 12:06AM CDT
Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 59.00 (+0.17), FULL: 3.52 (-0.01), CARA: 9.99 (-0.14)
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 112.25 (-0.07), FULL: 3.52 (-0.01), CARA: 9.99 (-0.14)
GrowBLOX Signs License Agreement Including Initial Royalty Payment of $300,000 on its New Technology for the Consistent Production of Medical Cannabis
ACCESSWIRE - Wed Feb 04, 7:53AM CST
Las Vegas, NV / ACCESSWIRE / February 4, 2015 / GrowBLOX Sciences, Inc., "GB Sciences" (GBLX), a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation, which are designed to produce consistent medicinal cannabis, has signed an agreement to license certain of its proprietary TissueBLOX technology to an unaffiliated licensed cannabis testing company. The licensed technology consists of certain equipment, procedures, and know-how related to the seedless propagation of genetically-identified strains of cannabis. The technology will enable the licensee to offer as a service to third-party growers the ability to grow specific strains of cannabis with an unprecedented level of reliability, precision, and most importantly, consistency of genetic material. As a practical matter what this means is that any grower, having developed and tested a strain of cannabis with certain characteristics desired by the grower, can provide for the continuous and consistent production of the genetics for that strain, enabling it to be branded as either a recreational or medicinal product.
99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST
GWPH: 112.25 (-0.07), FULL: 3.52 (-0.01), CARA: 9.99 (-0.14), ICN: 21.13 (+0.01)
Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST
GWPH: 112.25 (-0.07), FULL: 3.52 (-0.01), CARA: 9.99 (-0.14)
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST
GWPH: 112.25 (-0.07), DE: 89.13 (-3.08), FULL: 3.52 (-0.01), CARA: 9.99 (-0.14)
GrowBLOX Sciences Partners with Fuzhou Seechance Holding for Production of its Proprietary Growing Chambers
ACCESSWIRE - Mon Jan 12, 7:30AM CST
Untitled Document
GrowBLOX Sciences Executes Cannabis Supply Agreement with Provisionally Licensed Medical Cannabis Dispensary Facility
ACCESSWIRE - Wed Jan 07, 7:30AM CST
To Supply Medical Cannabis and Related Cannabis Products for Retail Sale; Retail Concessions for GB Sciences Nevada Brand-Name Products
GrowBLOX Sciences Provides Update on its Grow and Dispensary Efforts in Nevada
ACCESSWIRE - Wed Dec 17, 8:00AM CST
LAS VEGAS, NV / ACCESSWIRE / December 17, 2014 / GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, is pleased to update its shareholders on its efforts to receive the necessary licenses to grow and dispense medical cannabis in Nevada.
GrowBLOX Sciences Provides Update on its Cultivation Plans in Las Vegas
ACCESSWIRE - Tue Dec 16, 1:14PM CST
Recently Received Nevada State Approval Targets a 1st Half 2015 Start-Up Date for Commercialization
GrowBLOX Sciences Appoints Cathryn Kennedy as CFO
GlobeNewswire - Tue Dec 09, 2:25PM CST
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a company that focuses on plant biology and cultivation technology in order to optimize safe and consistent medical cannabis, today announced the appointment of Cathryn Kennedy as its Chief Financial Officer, effective immediately.
American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST
GWPH: 112.25 (-0.07), FULL: 3.52 (-0.01)